Suppr超能文献

Duchenne 型肌营养不良症的纵向时间功能测试:ImagingDMD 队列的自然史。

Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history.

机构信息

Department of Physical Therapy, University of Florida, Box 100154, UFHSC, Gainesville, Florida, 32610, USA.

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

出版信息

Muscle Nerve. 2018 Nov;58(5):631-638. doi: 10.1002/mus.26161. Epub 2018 Jul 24.

Abstract

INTRODUCTION

Tests of ambulatory function are common clinical trial endpoints in Duchenne muscular dystrophy (DMD). Using these tests, the ImagingDMD study has generated a large data set that can describe the contemporary natural history of DMD in 5-12.9-year-olds.

METHODS

Ninety-two corticosteroid-treated boys with DMD and 45 controls participated in this longitudinal study. Participants performed the 6-minute walk test (6MWT) and timed function tests (TFT: 10-m walk/run, climbing 4 stairs, supine to stand).

RESULTS

Boys with DMD had impaired functional performance even at 5-6.9 years old. Boys older than 7 had significant declines in function over 1 year for 10-m walk/run and 6MWT. Eighty percent of participants could perform all functional tests at 9 years old. TFTs appear to be slightly more responsive and predictive of disease progression than the 6MWT in 7-12.9 year olds.

DISCUSSION

This study provides insight into the contemporary natural history of key functional endpoints in DMD. Muscle Nerve 58: 631-638, 2018.

摘要

简介

在杜氏肌营养不良症(DMD)中,运动功能测试是常见的临床试验终点。通过这些测试,ImagingDMD 研究产生了一个大型数据集,可描述 5-12.9 岁 DMD 患儿的当代自然病史。

方法

92 名接受皮质类固醇治疗的 DMD 男孩和 45 名对照者参加了这项纵向研究。参与者进行了 6 分钟步行测试(6MWT)和计时功能测试(TFT:10 米步行/跑,爬 4 级楼梯,仰卧位站立)。

结果

即使在 5-6.9 岁时,患有 DMD 的男孩的功能表现也受损。7 岁以上的男孩在 1 年内 10 米步行/跑和 6MWT 的功能显著下降。80%的参与者在 9 岁时可以进行所有功能测试。在 7-12.9 岁的儿童中,TFT 似乎比 6MWT 更敏感,更能预测疾病进展。

讨论

这项研究深入了解了 DMD 中关键功能终点的当代自然病史。肌肉神经 58:631-638,2018。

相似文献

1
Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history.
Muscle Nerve. 2018 Nov;58(5):631-638. doi: 10.1002/mus.26161. Epub 2018 Jul 24.
4
Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests.
Pediatr Neurol. 2020 Dec;113:15-20. doi: 10.1016/j.pediatrneurol.2020.08.013. Epub 2020 Aug 27.
5
The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.
Muscle Nerve. 2010 Apr;41(4):500-10. doi: 10.1002/mus.21544.
9
Strong correlation between the 6-minute walk test and accelerometry functional outcomes in boys with Duchenne muscular dystrophy.
J Child Neurol. 2015 Mar;30(3):357-63. doi: 10.1177/0883073814530502. Epub 2014 Apr 23.
10
Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy.
PLoS One. 2018 Mar 19;13(3):e0194283. doi: 10.1371/journal.pone.0194283. eCollection 2018.

引用本文的文献

2
Is there a decline in speech and swallowing in Amyotrophic Lateral Sclerosis over ten years?
Codas. 2025 Feb 10;37(2):e20240159. doi: 10.1590/2317-1782/e20240159pt. eCollection 2025.
3
Meta-analysis of the efficacy and safety of vamorolone in Duchenne muscular dystrophy.
Neurol Sci. 2025 May;46(5):2249-2262. doi: 10.1007/s10072-024-07939-1. Epub 2024 Dec 24.
5
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.
Nat Med. 2025 Jan;31(1):332-341. doi: 10.1038/s41591-024-03304-z. Epub 2024 Oct 9.
7
Skeletal muscle symptoms and quantitative MRI in females with dystrophinopathy.
Muscle Nerve. 2024 Nov;70(5):988-999. doi: 10.1002/mus.28235. Epub 2024 Sep 2.
10
Distinguishing Clinical From Statistical Significances in Contemporary Comparative Effectiveness Research.
Ann Surg. 2024 Jun 1;279(6):907-912. doi: 10.1097/SLA.0000000000006250. Epub 2024 Feb 23.

本文引用的文献

1
Dystrophin Analysis in Clinical Trials.
J Neuromuscul Dis. 2014;1(1):41-53.
2
Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy.
Ann Neurol. 2016 Feb;79(2):257-71. doi: 10.1002/ana.24555. Epub 2016 Jan 8.
3
Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study.
Neurology. 2015 Sep 22;85(12):1048-55. doi: 10.1212/WNL.0000000000001950. Epub 2015 Aug 26.
4
Duchenne muscular dystrophy: clinical trials and emerging tribulations.
Curr Opin Neurol. 2015 Oct;28(5):542-6. doi: 10.1097/WCO.0000000000000243.
5
Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy.
Neuromuscul Disord. 2015 Sep;25(9):679-85. doi: 10.1016/j.nmd.2015.05.006. Epub 2015 Jun 4.
6
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes.
PLoS One. 2014 Oct 1;9(10):e108205. doi: 10.1371/journal.pone.0108205. eCollection 2014.
7
Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS.
Neurology. 2014 Sep 9;83(11):974-80. doi: 10.1212/WNL.0000000000000775. Epub 2014 Aug 6.
8
Ataluren treatment of patients with nonsense mutation dystrophinopathy.
Muscle Nerve. 2014 Oct;50(4):477-87. doi: 10.1002/mus.24332.
9
Exon-skipping therapy: a roadblock, detour, or bump in the road?
Sci Transl Med. 2014 Apr 2;6(230):230fs14. doi: 10.1126/scitranslmed.3008873.
10
6 Minute walk test in Duchenne MD patients with different mutations: 12 month changes.
PLoS One. 2014 Jan 8;9(1):e83400. doi: 10.1371/journal.pone.0083400. eCollection 2014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验